Comparison of Two Regimens of Liposomal Doxorubicin in Treating Women With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: pegylated liposomal doxorubicin hydrochloride
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC